Structure of pathological TDP-43 filaments from ALS with FTLD

被引:0
|
作者
Diana Arseni
Masato Hasegawa
Alexey G. Murzin
Fuyuki Kametani
Makoto Arai
Mari Yoshida
Benjamin Ryskeldi-Falcon
机构
[1] MRC Laboratory of Molecular Biology,Department of Brain and Neurosciences
[2] Tokyo Metropolitan Institute of Medical Science,Department of Psychiatry and Behavioural Sciences
[3] Tokyo Metropolitan Institute of Medical Science,Institute for Medical Science of Aging
[4] Aichi Medical University,undefined
来源
Nature | 2022年 / 601卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The abnormal aggregation of TAR DNA-binding protein 43 kDa (TDP-43) in neurons and glia is the defining pathological hallmark of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and multiple forms of frontotemporal lobar degeneration (FTLD)1,2. It is also common in other diseases, including Alzheimer’s and Parkinson’s. No disease-modifying therapies exist for these conditions and early diagnosis is not possible. The structures of pathological TDP-43 aggregates are unknown. Here we used cryo-electron microscopy to determine the structures of aggregated TDP-43 in the frontal and motor cortices of an individual who had ALS with FTLD and from the frontal cortex of a second individual with the same diagnosis. An identical amyloid-like filament structure comprising a single protofilament was found in both brain regions and individuals. The ordered filament core spans residues 282–360 in the TDP-43 low-complexity domain and adopts a previously undescribed double-spiral-shaped fold, which shows no similarity to those of TDP-43 filaments formed in vitro3,4. An abundance of glycine and neutral polar residues facilitates numerous turns and restricts β-strand length, which results in an absence of β-sheet stacking that is associated with cross-β amyloid structure. An uneven distribution of residues gives rise to structurally and chemically distinct surfaces that face external densities and suggest possible ligand-binding sites. This work enhances our understanding of the molecular pathogenesis of ALS and FTLD and informs the development of diagnostic and therapeutic agents that target aggregated TDP-43.
引用
收藏
页码:139 / 143
页数:4
相关论文
共 50 条
  • [21] TDP-43 in FTD and ALS
    Neumann, M.
    BRAIN PATHOLOGY, 2010, 20 : 7 - 7
  • [22] Codon-optimized TDP-43 mediates neurodegeneration in a Drosophila model of ALS/FTLD
    Yusuff, Tanzeen
    Chang, Ya-Chu
    Sang, Tzu-Kang
    Jackson, George R.
    Chatterjee, Shreyasi
    FRONTIERS IN GENETICS, 2023, 14
  • [23] Targeting the insoluble inclusions of TDP-43 by trodusquemine as a potential therapeutic strategy for ALS and FTLD
    Cascella, R.
    Bigi, A.
    Ermini, E.
    Staderini, T.
    Conti, A. C.
    Banchelli, M.
    Barbut, D.
    Zasloff, M.
    Chiti, F.
    Cecchi, C.
    FEBS OPEN BIO, 2024, 14 : 366 - 366
  • [24] Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD
    Wood, Alistair
    Gurfinkel, Yuval
    Polain, Nicole
    Lamont, Wesley
    Lyn Rea, Sarah
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [25] FTLD/ALS-linked TDP-43 mutations do not alter TDP-43's ability to self-regulate its expression in Drosophila
    Miguel, Laetitia
    Avequin, Tracey
    Pons, Marine
    Frebourg, Thierry
    Campion, Dominique
    Lecourtois, Magalie
    BRAIN RESEARCH, 2018, 1695 : 1 - 9
  • [26] Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS Patients
    Diana Posa
    Loreto Martínez-González
    Fernando Bartolomé
    Siranjeevi Nagaraj
    Gracia Porras
    Ana Martínez
    Ángeles Martín-Requero
    Molecular Neurobiology, 2019, 56 : 2424 - 2432
  • [27] Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
    Pickles, Sarah
    Gendron, Tania F.
    Koike, Yuka
    Yue, Mei
    Song, Yuping
    Kachergus, Jennifer M.
    Shi, J.
    DeTure, Michael
    Thompson, E. Aubrey
    Oskarsson, Bjorn
    Graff-Radford, Neill R.
    Boeve, Bradley F.
    Petersen, Ronald C.
    Wszolek, Zbigniew K.
    Josephs, Keith A.
    Dickson, Dennis W.
    Petrucelli, Leonard
    Cook, Casey N.
    Prudencio, Mercedes
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2022, 10 (01)
  • [28] Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
    Sarah Pickles
    Tania F. Gendron
    Yuka Koike
    Mei Yue
    Yuping Song
    Jennifer M. Kachergus
    J. Shi
    Michael DeTure
    E. Aubrey Thompson
    Björn Oskarsson
    Neill R. Graff-Radford
    Bradley F. Boeve
    Ronald C. Petersen
    Zbigniew K. Wszolek
    Keith A. Josephs
    Dennis W. Dickson
    Leonard Petrucelli
    Casey N. Cook
    Mercedes Prudencio
    Acta Neuropathologica Communications, 10
  • [29] Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS Patients
    Posa, Diana
    Martinez-Gonzalez, Loreto
    Bartolome, Fernando
    Nagaraj, Siranjeevi
    Porras, Gracia
    Martinez, Ana
    Martin-Requero, Angeles
    MOLECULAR NEUROBIOLOGY, 2019, 56 (04) : 2424 - 2432
  • [30] Mechanisms of Disease in FTLD - TDP-43 gain of function
    Bigio, Eileen H.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 3 - 3